Skip to main content
C

CryoLogyx

CryoLogyx develops cryopreserved, assay-ready cells that are directly adhered to microplates, enabling experiments to commence just 24 hours post-thaw. This technology enhances the precision and efficiency of cell-based research, significantly reducing the time and resources required for routine cell culture.

United KingdomFounded 2021101K+ followers
Updated 20 months ago

Funding

$636.3K raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.

OTOU
Funding rounds are not available yet.

Founders

Product

Problem

Traditional cell-based assays require extensive cell culture, which is time-consuming, resource-intensive, and can introduce variability, impacting the reproducibility and efficiency of research. The need for immediate experimentation post-thaw is unmet due to the time required for cell recovery and adherence.

Solution

CryoLogyx provides cryopreserved, assay-ready cells pre-adhered to microplates, enabling researchers to initiate experiments within 24 hours post-thaw. This technology bypasses the need for routine cell culture, reducing experimental timelines and minimizing variability. The company's patented cryopreservation formulation, CryoShield, integrates soluble ice nucleators to control ice nucleation and mitigate supercooling effects, which are easily removed post-thaw. CryoLogyx also offers CustomReady, a bespoke cell-banking service that tailors cryopreserved cells to specific research needs, ensuring high-quality, ready-to-use cells.

Target Audience

The primary customers are researchers in chemistry and biology, CROs, and cell bank innovation teams who perform cell-based assays and require efficient, reproducible, and high-quality cells.

Features

  • PlateReady: Cryopreserved cells directly adhered to microplates, ready for assays 24 hours post-thaw.
  • CryoShield: Patented cryopreservation formulation with nature-inspired soluble ice nucleators for controlled ice nucleation.
  • CustomReady: Customized cell-banking service tailored to specific research requirements.
  • Available cell lines include HepG2, A549, BHK-21, Vero, and THP-1.
  • CryoShield Red formulation available.
This profile is AI-generated and may contain inaccuracies.